Jeffrey M. Leiden
2019 - Vertex Pharmaceuticals
In 2019, Jeffrey M. Leiden earned a total compensation of $18.8M as Executive Chairman at Vertex Pharmaceuticals, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,510,000 |
|---|---|
| Option Awards | $4,572,039 |
| Salary | $1,300,000 |
| Stock Awards | $9,334,681 |
| Other | $73,265 |
| Total | $18,789,985 |
Leiden received $9.3M in stock awards, accounting for 50% of the total pay in 2019.
Leiden also received $3.5M in non-equity incentive plan, $4.6M in option awards, $1.3M in salary and $73.3K in other compensation.
Rankings
In 2019, Jeffrey M. Leiden's compensation ranked 188th out of 13,971 executives tracked by ExecPay. In other words, Leiden earned more than 98.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 188 out of 13,971 | 99th |
Division Manufacturing | 67 out of 5,701 | 99th |
Major group Chemicals And Allied Products | 18 out of 2,200 | 99th |
Industry group Drugs | 14 out of 1,886 | 99th |
Industry Pharmaceutical Preparations | 13 out of 1,398 | 99th |
Source: SEC filing on April 28, 2020.
Leiden's colleagues
We found six more compensation records of executives who worked with Jeffrey M. Leiden at Vertex Pharmaceuticals in 2019.
2019
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2019
Reshma Kewalramani
Vertex Pharmaceuticals
Chief Executive Officer
2019
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Patient Officer
2019
Charles Wagner
Vertex Pharmaceuticals
Chief Financial Officer
2019
Paul Silva
Vertex Pharmaceuticals
SVP & Corporate Controller
2019
Ian Smith
Vertex Pharmaceuticals